ITCH and gastric cancer: Moreover, Cir-ITCH significantly decreases the protein level of β-catenin and p-Dvl2 and two Wnt target genes c-Myc and cyclin D1, thus attenuating the cell proliferation, migration, and invasion in GC (24).